About Naari
Naari is a company based in Noida (India) founded in 2007 by Prithi S Kochhar was acquired by Tenshi Life Sciences in May 2017. Naari has raised $18.98 million across 3 funding rounds from investors including Jagsonpal, Ascent Capital and Tenshi Life Sciences. The company has 186 employees as of March 05, 2025. Naari operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Gameto, among others.
- Headquarter Noida, India
- Employees 186 as on 05 Mar, 2025
- Founders Prithi S Kochhar
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Naari Pharma Private Limited
- Date of Incorporation 23 Feb, 1978
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$14.02 M (USD)17.72as on Mar 31, 2024
-
Net Profit
$2.77 M (USD)149.28as on Mar 31, 2024
-
EBITDA
$4.11 M (USD)22.41as on Mar 31, 2024
-
Total Equity Funding
$18.98 M (USD)
in 3 rounds
-
Latest Funding Round
$17.53 M (USD), Private Equity Round
Dec 06, 2019
-
Investors
Jagsonpal
& 3 more
-
Employee Count
186
as on Mar 05, 2025
-
Acquired by
Tenshi Life Sciences
(May 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Naari
Unlock access to complete
Unlock access to complete
Funding Insights of Naari
Naari has successfully raised a total of $18.98M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $17.53 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Private Equity Round — $17.5M
-
First Round
First Round
(03 Dec 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Private Equity Round - Naari | Valuation | Ascent Capital |
|
| Oct, 2019 | Amount | Series A - Naari | Valuation | Jagsonpal |
|
| Dec, 2008 | Amount | Grant - Naari | Valuation |
investors |
Investors in Naari
Naari has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Jagsonpal, Ascent Capital and Tenshi Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine.
|
Founded Year | Domain | Location | |
|
Traditional company manufacturing bulk drugs and finished formulations
|
Founded Year | Domain | Location | |
|
Resources and assistance are provided to HUD's community partners.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Naari
Financial Statements - Naari
Naari Comparisons
Competitors of Naari
Naari operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Gameto, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Therapeutics for fertility and menopause treatments are developed.
|
Frequently Asked Questions about Naari
Naari was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Naari is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
Prithi S Kochhar is the current CEO of Naari. They have also founded this company.
Naari is a funded company, having raised a total of $18.98M across 3 funding rounds to date. The company's 1st funding round was a Grant of $53.69K, raised on Dec 03, 2008.
As of Mar 05, 2025, the latest employee count at Naari is 186.
Annual revenue of Naari is $14.02M as on Mar 31, 2024.
Naari manufacturer of women care medicines, focusing on life sciences, women health, drugs, and reproductive diseases. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Naari's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Naari has 4 investors. Key investors include Jagsonpal, Ascent Capital, Tenshi Life Sciences, and HUD Exchange.
The valuation of Naari is $86.27M as of Dec 2019.